E. Gernez

Nitrous oxide abuse direct measurement for diagnosis and follow-up: update on kinetics and impact on metabolic pathways

S. Anthérieu, Alastair J Noyce, Guillaume Garçon, 2024, Clinical chemistry and laboratory medicine.

Nitrous Oxide Abuse: Clinical Outcomes, Pharmacology, Pharmacokinetics, Toxicity and Impact on Metabolism

E. Gernez, Guillaume Grzych, Graham Robert Lee, 2023, Toxics.

Awareness of health care related to nitrous oxide abuse for diagnosis, treatment and follow-up

G. Grzych, A. Bennis, Emeline Gernez, 2023, Irish journal of medical science.

Comparison of biomarker for diagnosis of nitrous oxide abuse: challenge of cobalamin metabolic parameters, a retrospective study

C. Tard, D. Dobbelaere, P. Pigny, 2023, Journal of Neurology.

Plasma Methionine and Clinical Severity in Nitrous Oxide Consumption

C. Tard, S. Deheul, C. Douillard, 2022, Toxics.

[Methylmalonic acid: Specific marker of chronic nitrous oxide abuse?]

G. Grzych, E. Gernez, S. Deheul, 2022, La Revue de medecine interne.

Understanding Neuropathy Features in the Context of Nitrous Oxide Abuse: A Combined Electrophysiological and Metabolic Approach

E. Gernez, Guillaume Grzych, B. Touze, 2024, Biomedicines.

What biological markers could be used for diagnosis and monitoring of nitrous oxide abuse?

Alastair Noyce, Angèle Lucas, E. Gernez, 2023, European journal of neurology.